Dynamic Modeling of Cortisol Reduction after Inhaled Administration of Fluticasone Propionate
暂无分享,去创建一个
A Bye | H Derendorf | B. Meibohm | H. Möllmann | H. Derendorf | B Meibohm | S. Rohatagi | A. Bye | S Rohatagi | C. Falcoz | A. Mackie | C Falcoz | A E Mackie | H Möllmann | Shashank Rohatagi | Christine Falcoz | Bernd Meibohm | Hartmut Derendorf
[1] B. Spilker. Guide to clinical trials , 1991 .
[2] G. Harrison,et al. A sensitive radioimmunoassay, incorporating solid-phase extraction, for fluticasone 17-propionate in plasma. , 1993, Journal of pharmaceutical and biomedical analysis.
[3] H. Möllmann,et al. Pharmacokinetic and Pharmacodynamic Evaluation of Triamcinolone Acetonide After Intravenous, Oral, and Inhaled Administration , 1995, Journal of clinical pharmacology.
[4] M. Johnson,et al. Fluticasone propionate--an update on preclinical and clinical experience. , 1995, Respiratory medicine.
[5] S. Tunn,et al. Pharmacokinetics and Oral Bioavailability of Hydrocortisone , 1991, Journal of clinical pharmacology.